Suanfarma
Suanfarma is involved in the development, manufacture, and distribution of raw materials and finished dosage forms for various sectors including pharmaceuticals, biotechnology, veterinary, nutrition, and cosmetics. The company provides a diverse range of products that includes generics and active pharmaceutical ingredients for various therapeutic areas such as anti-infectives, cardiovascular, central nervous system, oncology, and pain management. Additionally, it offers food supplements and medicinal plants, as well as active ingredients tailored for the veterinary industry. Suanfarma also focuses on developing alternative synthesis routes for active pharmaceutical ingredients and supports early-stage biotechnology companies with expertise in scientific, regulatory, and commercial management. Founded in 1993 and headquartered in Alcobendas, Spain, the company has a global presence with locations in the Americas, Europe, the Middle East, and Asia.
Cipan specializes in the research, development and production of active pharmaceutical ingredients, primarily anti-infection agents.
Idifarma Desarrollo Farmacéutico, S.L., founded in 2001 and based in Noain, Spain, specializes in contract development and manufacturing services for the pharmaceutical and biotechnological sectors, both domestically and internationally. The company offers a comprehensive array of contract development services, including active pharmaceutical ingredient (API) selection, analytical development, formulation development, GMP manufacturing, quality control, batch release, stability studies, clinical trial logistics management, and regulatory affairs. Additionally, Idifarma provides GMP contract manufacturing and packaging services for investigational medicinal products and human use medicinal products in both clinical and commercial batches. Serving a diverse clientele that ranges from start-ups to multinational corporations, Idifarma caters to various needs, from generic medications to new active ingredients.
PEVESA is a biotechnology company that specializes in the development and manufacturing of nutritional food ingredients and protein derivatives. The company focuses on utilizing proteins to create isolates, hydrolysates, peptides, and amino acids, employing biological catalysts such as enzymes in its processes. PEVESA's strength lies in its ability to develop custom products tailored to the specific needs of its clients. The company aims to establish itself as a leader in customized production across various sectors, including food, nutraceuticals, fermentation media, cosmetics, and bio-agriculture. Through its innovative approach, PEVESA seeks to provide healthy food options and supplements for consumers.
3P Biopharmaceuticals operates in the field of Biotechnology, one of the most innovative areas of activity and with the greatest scope for growth within the economies of the world´s most developed countries. Biotechnology plays a key role in the welfare of 21st century society due to its far reaching involvement in the improvement of the health and welfare of individuals, in agriculture, the environment and in the use of energy.
Digna Biotech is a biotechnology company based in Pamplona, Spain, originating from the Centre for Applied Medical Research (CIMA) at the University of Navarra. It is co-owned by the Foundation for Applied Medical Research and a consortium of private investors, which includes prominent institutions such as the University of Navarra and the Government of Navarra. The company focuses on developing therapeutic and diagnostic products aimed at treating acute hospital cases. Digna Biotech utilizes advanced scientific and clinical expertise to transform early-stage medical innovations into candidates suitable for clinical development and commercialization.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.